56 related articles for article (PubMed ID: 29451702)
1. Severity of cerebral palsy and likelihood of adverse events after botulinum toxin A injections.
Swinney CM; Bau K; Burton KLO; O'Flaherty SJ; Bear NL; Paget SP
Dev Med Child Neurol; 2018 May; 60(5):498-504. PubMed ID: 29451702
[TBL] [Abstract][Full Text] [Related]
2. Adverse events after different forms of botulinum neurotoxin A injections in children with cerebral palsy: An 8-year retrospective study.
Dev Med Child Neurol; 2024 Jul; 66(7):e81. PubMed ID: 38773794
[No Abstract] [Full Text] [Related]
3. Safety of botulinum toxin injections in children less than one year old: A retrospective chart review.
Deshpande N; Gormley ME; Deshpande S
J Pediatr Rehabil Med; 2024; 17(1):67-73. PubMed ID: 37574745
[TBL] [Abstract][Full Text] [Related]
4. Treatment of oromandibular dystonia with botulinum toxin A improves apnea in a teenager with quadriplegic cerebral palsy: A case report.
Roberts J; Tenaglia A; Bellissimo E; Kim H
J Pediatr Rehabil Med; 2024; 17(1):125-129. PubMed ID: 37522227
[TBL] [Abstract][Full Text] [Related]
5. The Etiologic Risk Factors for Cerebral Palsy at an Orthopedic Surgery Clinic in South Africa.
Maimin D; Mentz A; Thomas M; Van Heerden TM; Horn A
Pediatr Neurol; 2024 Apr; 153():175-178. PubMed ID: 38412782
[TBL] [Abstract][Full Text] [Related]
6. Community-based physical activity interventions for adolescents and adults with complex cerebral palsy: A scoping review.
Morgan P; Cleary S; Dutia I; Bow K; Shields N
Dev Med Child Neurol; 2023 Nov; 65(11):1451-1463. PubMed ID: 37032538
[TBL] [Abstract][Full Text] [Related]
7. Correspondence between Expected, Perceived, and Measured Effects of BoNT-A Treatment in Calf Muscles among Children and Adolescents with Cerebral Palsy: A Mixed Methods Study.
Sæther R; Elvrum AG; Brændvik SM
J Clin Med; 2024 Mar; 13(5):. PubMed ID: 38592286
[TBL] [Abstract][Full Text] [Related]
8.
Romaen K; Van Ussel I; Van Rossem C; Kenis S; Ceulemans B; Van Hoorenbeeck K; Verhulst S
Front Pediatr; 2023; 11():1267345. PubMed ID: 38027271
[TBL] [Abstract][Full Text] [Related]
9. Botulinum Toxin for the Treatment of Cyclic Strabismus in Children: Three Case Reports.
Wipf M; Bok-Beaube C; Palmowski-Wolfe A
Klin Monbl Augenheilkd; 2018 Apr; 235(4):465-468. PubMed ID: 29452451
[TBL] [Abstract][Full Text] [Related]
10. Systemic adverse events after botulinum neurotoxin A injections in children with cerebral palsy.
Paget SP; Swinney CM; Burton KLO; Bau K; O'Flaherty SJ
Dev Med Child Neurol; 2018 Nov; 60(11):1172-1177. PubMed ID: 30146721
[TBL] [Abstract][Full Text] [Related]
11. Botulinum Toxin in the Management of Children with Cerebral Palsy.
Multani I; Manji J; Hastings-Ison T; Khot A; Graham K
Paediatr Drugs; 2019 Aug; 21(4):261-281. PubMed ID: 31257556
[TBL] [Abstract][Full Text] [Related]
12. State of the Evidence Traffic Lights 2019: Systematic Review of Interventions for Preventing and Treating Children with Cerebral Palsy.
Novak I; Morgan C; Fahey M; Finch-Edmondson M; Galea C; Hines A; Langdon K; Namara MM; Paton MC; Popat H; Shore B; Khamis A; Stanton E; Finemore OP; Tricks A; Te Velde A; Dark L; Morton N; Badawi N
Curr Neurol Neurosci Rep; 2020 Feb; 20(2):3. PubMed ID: 32086598
[TBL] [Abstract][Full Text] [Related]
13. Use of botulinum toxin A in children with cerebral palsy.
Ross Raftemo AE; Mahendran A; Hollung SJ; Jahnsen RB; Lydersen S; Vik T; Andersen GL
Tidsskr Nor Laegeforen; 2019 May; 139(8):. PubMed ID: 31062563
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy.
Blumetti FC; Belloti JC; Tamaoki MJ; Pinto JA
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD001408. PubMed ID: 31591703
[TBL] [Abstract][Full Text] [Related]
15. The Rehabilitation Interventions and Adaptive Technologies Used for Treating Patients With Cerebral Palsy.
Guru A; Yadav AS; Sontakke T
Cureus; 2023 Nov; 15(11):e49153. PubMed ID: 38130572
[TBL] [Abstract][Full Text] [Related]
16. Time-matched accelerometers on limbs and waist in children with CP give new insights into real-life activities after botulinum toxin treatment: A proof of concept study.
Gantelius S; Vikerfors S; Edqvist JJ; von Walden F; Hagströmer M; Pontén E
J Pediatr Rehabil Med; 2023; 16(1):125-137. PubMed ID: 36314229
[TBL] [Abstract][Full Text] [Related]
17. Long-term effect of botulinum toxin A on the hip and spine in cerebral palsy: A national retrospective cohort study in Taiwan.
Lin CY; Chung CH; Matthews DJ; Chu HY; Chen LC; Yang SS; Chien WC
PLoS One; 2021; 16(7):e0255143. PubMed ID: 34293010
[TBL] [Abstract][Full Text] [Related]
18. Diaphragm neuromuscular transmission failure in a mouse model of an early-onset neuromotor disorder.
Fogarty MJ; Brandenburg JE; Sieck GC
J Appl Physiol (1985); 2021 Mar; 130(3):708-720. PubMed ID: 33382958
[TBL] [Abstract][Full Text] [Related]
19. A prospective study investigating gross motor function of children with cerebral palsy and GMFCS level II after long-term Botulinum toxin type A use.
Valentine J; Davidson SA; Bear N; Blair E; Paterson L; Ward R; Forbes D; Elliott C
BMC Pediatr; 2020 Jan; 20(1):7. PubMed ID: 31906902
[TBL] [Abstract][Full Text] [Related]
20. Comment on: "Botulinum Toxin in the Management of Children with Cerebral Palsy".
Langdon K; Copeland L; Edwards P; Rodwell K; McLennan K; Carroll T; Bandaranayake S; Scheinberg A; Waugh MC; Burnett H; Wimalasundera N; Hennel S; Lim E; O'Flaherty S
Paediatr Drugs; 2019 Dec; 21(6):493-495. PubMed ID: 31583614
[No Abstract] [Full Text] [Related]
[Next] [New Search]
